FDA DEVICE FACTS
Nitrile Exam Glove, Extended cuff, Tested For Use With Chemotherapy Drugs, Fentanyl Citrate, And Select Other Drugs
Zhonghong Pulin Medical Products Co., Ltd.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
A patient examination gloves is a disposable device intended for medical purpose that is worn on the examiner’s hand or fingers to prevent contamination between patient and examiner. In addition, these gloves were tested for use with chemotherapy drugs, Fentanyl Citrate, and select other drugs in accordance with ASTM D6978- 05 Standard Practice for Assessment of Medical gloves to Permeation by Chemotherapy Drugs. Chemotherapy Drug Concentration Breakthrough Detection Time (minutes) Bendamustine HCl 5 mg/ml (5,000 ppm) > 240 Bleomycin Sulfate 15 mg/ml (15,000 ppm) > 240 Busulfan 6 mg/ml(6,000 ppm) > 240 Carboplatin 10.0 mg/ml (10,000 ppm) > 240 Carfilzomib 2 mg/ml (2,000 ppm) > 240 Carmustine 3.3 mg/ml (3,300 ppm) 21.1 (24.2, 21.1, 25.3) Cetuximab 2 mg/ml (2,000 ppm) > 240 Cisplatin 1 mg/ml (1000 ppm) > 240 Cladribine 1 mg/ml (1000 ppm) > 240 Cyclophosphamide 20 mg/ml (20.000 ppm) > 240 Cytarabine(Cytosine) 10 mg/ml(10,000 ppm) > 240 Cytovene(Ganciclovir) 100.0 mg/ml (100,000 ppm) > 240 Dacarbazine 10 mg/ml(10,000 ppm) > 240 Daunorubicin HCl 5 mg/ml (5,000 ppm) > 240 Decitabine 5 mg/ml(5,000 ppm) > 240 Docetaxel 10 mg/ml (10.000 ppm) > 240 Doxorubicin HCl 2 mg/ml (2,000 ppm) > 240 Epirubicin HCI (Ellence) 20 mg/ml (20,000 ppm) > 240 Etoposide 20 mg/ml (20,000 ppm) > 240 Fludarabine 25.0 mg/ml (25,000 ppm) > 240 Fluorouracil 50 mg/ml,(50,000 ppm) > 240 Fulvestrant 50 mg/ml(50,000 ppm) > 240 Gemcitabine 38 mg/ml (38,000 ppm) > 240 Idarubicin HCL 1.0 mg/ml (1,000 ppm) > 240 lfosfamide 50 mg/ml (50,000 ppm) > 240 lrinotecan HCl 20 mg/ml (20,000 ppm) > 240 Mechlorethamine HCl 1 mg/mI(1,000 ppm) > 240 Melphalan 5 mg/ml(5000 ppm) > 240 Methotrexate 25 mg/ml (25,000 ppm) > 240 Mitomycin C 0.5 mg/ml (500 ppm) > 240 Mitoxantrone HCL 2 mg/ml (2,000 ppm) > 240 Oxaliplatin 5 mg/ml (5,000 ppm) > 240 Paclitaxel 6 mg/ml (6,000 ppm) > 240 Paraplatin 10 mg/ml (10,000 ppm) > 240 Pemetrexed 25 mg/ml (25,000 ppm) > 240 Raltitrexed 0.5 mg/ml (500 ppm) > 240 Rituximab 10 mg/ml (10,000 ppm) > 240 Temsirolimus 25 mg/ml (25,000 ppm) > 240 Thiotepa 10 mg/ml(10,000 ppm) 74.9 (74.9, 96.7, 79.0) Topotecan 1 mg/ml (1,000 ppm) > 240 Nitrile Exam Glove, Extended cuff, Tested For Use With Chemotherapy Drugs And Fentanyl Permeation Resistance Claim Trisenox (Arsenic Trioxide) 1 mg/ml (1,000 ppm) > 240 Vinblastine, 1 mg/ml (1,000 ppm) > 240 Vincristine sulfate (Oncovin) 1 g/ml (1,000 ppm) > 240 Vinorelbine 10 mg/ml(10,000 ppm) > 240
Fentanyl Citrate and other Drugs Concentration Breakthrough Detection Time (minutes) Chloroquine 50 mg/m (50,000 ppm) > 240 Cyclosporin A 100.0 mg/ml (100,000 ppm) > 240 MESNA 100 mg/ml(100,000 ppm) > 240 Retrovir 10 mg/ml(10,000 ppm) > 240 Triclosan 3 mg/ml(3,000 ppm) > 240 Zoledronic Acid 1 mg/25ml (40 ppm) > 240 Fentanyl Citrate Injection 100mcg/2mL > 240
Note: The maximum testing time is 240 minutes. And testing showed minimum breakthrough time of 21.1 minutes with Carmustine (3.3 mg/ml), 74.9 minutes with Thio Tepa (10 mg/ml). Warning: Do not use with Carmustine and Thiotepa.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。